Loading clinical trials...
Loading clinical trials...
Phase II Clinical Trial With the Combination Gemcitabine, Oxaliplatin and Vinorelbine as First Line Treatment in Patients With Non-small Cell Bronchopulmonary Cancer
Conditions
Interventions
oxaliplatine / gemcitabine / Vinorelbine
Locations
1
France
Sanofi-Aventis
Paris, France
Start Date
June 1, 2003
Completion Date
October 1, 2006
Last Updated
December 7, 2009
NCT06066138
NCT07485114
NCT05098132
NCT06284317
NCT06731413
NCT06687369
Lead Sponsor
Sanofi
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions